O-(Propargyl)-N-(triethoxysilylpropyl)carbamate (inhibited with MEHQ), 90%, 250mg

(3,4-Difluoro-2-methoxyphenyl)boronic acid, 95.0%, 5g

(3aS,8aR)-2-(5-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 95%, 250mg

Methyl 4-amino-1H-pyrazole-3-carboxylate, 95.0%, 250mg

4-(Piperidin-4-yloxy)quinazoline hydrochloride, 1g

6-chloro-2-(4-morpholinyl)-4-pyrimidinamine, 95.0%, 5g

2,6-DIMETHYL-4-UNDECYLMORPHOLINE, 95.0%, 250mg

tert-Butyl 2-bromo-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 97%, 1g

(S)-1-Cyclopropylethanamine hydrochloride, 95.0%, 250mg

N,N-Dimethyl-2-(methylamino)acetamide hydrochloride, 95.0%, 25g

VIPADENANT, 95%, 25mg

Caffeic acid phenethyl ester, min. 99%, for biochemistry, 25 mg, glass packaging

C-(4-Methoxy-pyridin-2-yl)-)-methylamine, 95.0%, 250mg